Please log in when you are ready to upload the following documents:
A. Title page
Please provide the following information:
- A concise and informative title
- The name(s) of the author(s)
- The affiliation(s) of the author(s), i.e. institution, (department), city, (state), country
- The name and e-mail address of corresponding author
B. Abstract page
- The abstract will summarize the main facts, findings and principal conclusions.
- It should not contain any undefined abbreviations or references.
- Information on the structure and maximum number of words, depending on the type of paper, can be found in Table 1. For more details, please click on the type of paper you are interested in.
- Please provide 3 to 10 keywords that can be used for indexing purposes.
- Trial registration number and date of registration (if applicable).
- File type – Microsoft Word (.doc)
- Page design – A4, normal margins (2,54 cm top, bottom, left, right)
- Page numbering – bottom middle of the page
- Format – Arial, size 11, spacing 1.15 lines
The structure and requirements depend on the type of manuscript (please see Table 1 and click on the category to see further details).
|Tables and figures
Table 1. Types of Articles and general requirements (*Background, Material & Methods, Results, Conclusion; ** Importance, Observations, Conclusions & Relevance)
2. List of abbreviations
If abbreviations are used they should be defined in the text at first use, and a list of abbreviations in alphabetical order should be provided at the end of the body of the paper. (ESMO – European Society for Medical Oncology)
Please be sure to add the following statements regarding:
Each author is expected to have made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work; or have drafted the work or substantively revised it; AND has approved the submitted version (and version substantially edited by journal staff that involves the author’s contribution to the study); AND agrees to be personally accountable for the author’s own contributions and for ensuring that questions related to the accuracy or integrity of any part of the work, even ones in which the author was not personally involved, are appropriately investigated, resolved, and documented in the literature.
Example: XX and XY conceived and planned the analysis. ZY, ZZ contributed to the interpretation of the results. XZ took the lead in writing the manuscript. YY and XX made the final approval. All authors provided critical feedback and helped shape the research, analysis, and manuscript.
Consent for publication
Please mention: “As the corresponding author, I confirm that the manuscript has been read and approved for submission by all named authors.”
Conflict of interests
Authors must identify and declare any personal circumstances or interest that may be perceived as inappropriately influencing the representation or interpretation of reported research results. If there is no conflict of interest, please state “The authors declare no conflict of interest.”
All sources of funding for the study should be disclosed. Clearly indicate grants that you have received in support of your research work and if you received funds to cover publication costs. If there was no funding, please mention “None”
Statement of Ethics
Please mention if the manuscript does/does not contain any studies carried out by the authors on humans or animals and if it was approved by an Ethics Committee
Written informed consent for publication (for case reports)
Please mention “The informed consent was obtained from the patient for publication of this case report and any accompanying images.”
Please feel free to mention people/organizations that supported your project.
- References must be numbered in order of appearance in the text and follow the Vancouver referencing style, Author(s) – Family name and initials. Title of article. Abbreviated journal title. Publication year, month, day (month & day only if available); volume(issue):pages. (including table captions and figure legends) and listed individually at the end of the manuscript.
- We recommend preparing the references with a bibliography software package, such as Endnote, Mendeley or Zotero to avoid typing mistakes and duplicated references. The maximum number of references depends on the type of paper. Please check the detailed information here
- Citations and References in Supplementary files are permitted provided that they also appear in the main text and in the reference list.
- In the text, reference numbers should be placed in brackets ( ), and placed before the punctuation; for example (1), (1–3) or (1,3).
D. Supplementary Materials
Describe any supplementary material published online alongside the manuscript (figure, tables, video, spreadsheets, etc.). Please indicate the name and title of each element as follows Figure 1: title, Table 1: title, etc. When mentioned in the text, they should appear in round brackets: (Fig.1) (Table 1), etc
- Format – JPEG
- Resolution >300 dpi
- Sent separately (not embedded in the manuscript).
- Figure captions should be also sent separately in a .doc file and begin with the term Fig. in bold type, followed by the figure number and figure title (also in bold) and a concise legend describing accurately what the figure depicts.
- Add permissions to reproduce the figures and references if applicable.
- Numbered using Arabic numerals
- Cited in text in consecutive numerical order.
- For each table, please supply a table caption explaining the components of the table.
- Define any abbreviations, symbols or footnotes.
Ethical guidelines: authors must comply to the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (http://www.icmje.org/recommendations/).
Informed consent: Please make sure that you have copies of the patients᾽ signed consent forms in which patients or relatives in case the patient cannot, clearly state permission for inclusion in the study and/or the publication of photographs or other material that might identify them. Any patient identification data should be anonymized (name, surname, ID), and patient consent should be obtained where there is any doubt of patient anonymity.
Correspondence: in case of comments to the published case, the Editor-in-Chief will provide relevant comments to authors and will ask them to respond to peer criticism.